4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-22-050816
Director acquired 10,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WHITFIELD ROY A Director | 2022-09-16 | Grant or award | +10,200 | 246,250 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| WHITFIELD ROY A Director | 2022-09-16 | Grant or award · Stock Option | +20,400 | 20,400 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…